Skip to content

Medurva

Active
Private limited companyfounded 2025incorporated this yearNadine Crappéstraat 40, 9000 Gent, BelgiumKBO/BCE: BE 1028.644.121
Summary

Medurva is younger than twelve months; there is no public track record yet to compute a bankruptcy probability from. The 2025 annual accounts show equity of €19,368 and a net result of €14,368. The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals.

Risk analysisWatch ReportCompare
MedurvaActiveChecked score 83/100
Risk analysis ReportCompare

Checked score

Score 2025
83 / 100
Excellent
Every signal that weighs is under Signals.
Axes
Profitability100
Solvency75
Growth-
Track record50
Credit verdict
Credit up to €1,500 at 30 days acceptable
Liquidity ample (current ratio 1.93; short-term debt: 49.7% and cash: 49.7% of total assets), and 49.7% of the assets are financed with debt.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Two signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Young company
Founded in 2025, under 3 years in business. Failure risk is statistically highest between 2 and 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 0 years 0 10 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-07-2026, 4 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
4 d early
← before the deadline after the deadline →
Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

Medurva was incorporated on 3 October 2025 as a Private limited company.1 The company has filed annual accounts once, for fiscal year 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2025

Go further with this company

How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Roughly what is this company worth?Value indication

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€19,368
Total assets
€38,523
Net result
€14,368
Working capital
€17,864

Turnover and EBIT margin not published: the micro schema does not require them.

Balance-sheet composition
Assets €38,523
Fixed assets €1,504
Current assets €37,019
Equity and liabilities €38,523
Equity €19,368
Debt €19,155
Debt finances 49.7% of the balance-sheet total.
Key figures and ratios
2025 value
EBITDA
€18,349
Cash flow
€14,502
Current ratio
1.93
Debt to equity
0.99
ROE
74.2%
ROA
37.3%
Interest coverage
179.34
Debt ≤ 1 year
€19,155
Income taxes
€3,745
Annual accounts
Filed annual accounts As filed with the NBB · 2025 · 34 lines
Balance sheet Code2025
Assets
Total assets20/58€38,523
Fixed assets21/28€1,504
Tangible fixed assets22/27€1,504
Furniture and vehicles24€1,504
Current assets29/58€37,019
Amounts receivable within one year40/41€3,053
Trade receivables40€3,053
Cash at bank and in hand54/58€19,137
Deferred charges and accrued income490/1€14,830
Equity and liabilities
Total equity and liabilities10/49€38,523
Equity10/15€19,368
Contributions10/11€5,000
Reserves13€14,368
Distributable reserves133€14,368
Amounts payable17/49€19,155
Amounts payable within one year42/48€19,155
Trade debts44€2,663
Suppliers440/4€2,663
Taxes, remuneration and social security45€3,745
Taxes450/3€3,745
Other amounts payable47/48€12,747
Income statement Code2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€133
Other operating charges640/8€278
Gross operating margin9900€18,626
Operating profit (loss)9901€18,215
Financial charges65/66B€102
Recurring financial charges65€102
Profit (loss) for the period before taxes9903€18,113
Income taxes67/77€3,745
Profit (loss) for the period9904€14,368
Profit (loss) for the period to be appropriated9905€14,368
Appropriation of the result
Profit (loss) to be appropriated9906€14,368
Transfer to equity691/2€14,368
To other reserves6921€14,368

The notes to these accounts (5 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line2025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€133
Other operating charges640/8€278
Gross operating margin9900€18,626
Operating profit (loss)9901€18,215
Financial charges65/66B€102
Recurring financial charges65€102
Profit (loss) for the period before taxes9903€18,113
Income taxes67/77€3,745
Profit (loss) for the period9904€14,368
Profit (loss) for the period to be appropriated9905€14,368
Line2025
Assets
Total assets20/58€38,523
Fixed assets21/28€1,504
Tangible fixed assets22/27€1,504
Furniture and vehicles24€1,504
Current assets29/58€37,019
Amounts receivable within one year40/41€3,053
Trade receivables40€3,053
Cash at bank and in hand54/58€19,137
Deferred charges and accrued income490/1€14,830
Equity and liabilities
Total equity and liabilities10/49€38,523
Equity10/15€19,368
Contributions10/11€5,000
Reserves13€14,368
Distributable reserves133€14,368
Amounts payable17/49€19,155
Amounts payable within one year42/48€19,155
Trade debts44€2,663
Suppliers440/4€2,663
Taxes, remuneration and social security45€3,745
Taxes450/3€3,745
Other amounts payable47/48€12,747
Line2025
Profit (loss) for the period9904€14,368
+ Depreciation and write-downs630€133
Operating cash flow (approximation)€14,502

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2026
27-07
NBB filing Annual accounts filed
fiscal year 2025 · micro schema
NBB filing
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
No directors read yet: 0 of 1 Gazette acts processed. See the function holders in the CBE →
Location & real-estate footprint
Registered office, Gent · 1 establishment unit since 2025
seat establishment The establishment unit on the map
Ground area
7,066 m²
Building footprint
294 m²
Volume, LiDAR
3,857 m³
Parcel 44342B0637/00V002, Flanders · tallest building 14.7 m, ±4 floors. Linked by address, not a title deed.
5 companies at this address See who is registered here
1 establishment unit
Medurva
Nadine Crappéstraat 40, 9000 GentGeneral medical practice
since 20252.379.519.866
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44342B0637/00V002 Flanders 7,066 m² 1 · 294 m² 14.7 m · 4 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Company details

Identification
Legal formPrivate limited company
Founded03-10-2025
Fiscal year end31-12
E-invoicing
Reachable via Peppol
Peppol ID 0208:1028644121
Also 9925:BE1028644121
Registered 12-11-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 1 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

We would like to set cookies. That happens only with your consent. What we measure